JARBAS BARBOSA
Quinta-feira 26 de Abril de
2018
· 16:00
- Missão internacional
Atividade:
World Orphan Drug Congress USA 2018 BRAZIL: accelerating the review and
approval of orphan drugs in Latin America’s largest market • Resolution to
establish a procedure for clinical trials consent and good manufacturing
practices • Guidelines for registration of new drugs for treatment, diagnosis
or prevention of rare diseases • What this means for patients, drug
manufacturers and the healthcare system
Local:
Washington/EUA
0 comentários:
Postar um comentário